Cancer Cells and MetastasisCancer Genomics and DiagnosticsBRCA gene mutations in cancerEstrogen and related hormone effectsGene expression and cancer classification
Publications
715
Citations
17,873
Est. group size
~2
Recurring co-author estimate
Active years
39
Publishing since 1988
Publication cadence
Publications per year over the last 10 years — averaging 79.8/year recently
Recent publications
- Abstract PS2-09-19: Tonsl, an immortalizing oncogene on chr.8q24.3 amplicon, confers intrinsic resistance to cdk4/6 inhibitors in breast cancer
Clinical Cancer Research · 2026
- Abstract 3006: Genomic determinants of PIK3CA mutation driven breast cancer initiation
Cancer Research · 2026
- Abstract 7293: The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability
Cancer Research · 2026
- Abstract 6326: Pregnancy, lactation, and involution-induced remodeling and cell state changes in breast tissues of healthy women
Cancer Research · 2026
- Influence of <i>TONSL</i> on tumor suppressor function of <i>RAD51</i> and resistance to CDK4/6 inhibitors in ER+ breast cancer.
Journal of Clinical Oncology · 2026
- Abstract 2587: Transcription factor ZEB1 controls lineage specificity of African ancestry-enriched breast stromal multilineage cells
Cancer Research · 2025
- GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
JAMA Oncology · 2025
- Defining breast epithelial cell types in the single-cell era
Developmental Cell · 2025
- MammOnc-DB, an integrative breast cancer data analysis platform for target discovery
npj Breast Cancer · 2025
- Ancestry-linked stromal variations impact breast epithelial cell invasion
iScience · 2025
- Challenges and opportunities in training cancer researchers
Nature Cancer · 2025
- Abstract P3-05-23: Single nucleus chromatin accessibility and transcriptome analyses reveal aberrant inter-cellular communication in inflammatory breast cancer
Clinical Cancer Research · 2025
- Abstract PS13-04: DREAM complex assembly and stable cell cycle control underlies long-term clinical response to CDK4/6 inhibition
Clinical Cancer Research · 2025
- Hands-on summer research programs at Indiana university Simon comprehensive cancer center
Discover Education · 2025
- Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
Cancer Cell · 2024
Publishes in
- Cancer Research×41
- Figshare×27
- PMC×15
- bioRxiv (Cold Spring Harbor Laboratory)×13
- Clinical Cancer Research×6
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile